PREVENTION & CONTROL OF CANCER, DIABETES, CARDIOVASCULAR DISEASES & STROKE PROGRAMME

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

In order to prevent and control major Non-Communicable Diseases, Government of India is implementing the NPCDCS in all States across the country with the focus on strengthening infrastructure, human resource development, health promotion, early diagnosis, management and referral. Progress so...

Read More

Nearly 1.5 lakh Primary Health Centres would be transformed as Health & Wellness Centres by 2022

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

Ayushman Bharat-Health & Wellness Centres (AB-HWC) Delivery of comprehensive primary health care services through Health &Wellness Centres is a critical component of the newly announced Ayushman Bharat scheme. It places people and communities at the center of the health care...

Read More

Zydus receives approvals from USFDA for Betamethasone Dipropionate Cream and Amlodipine & Atorva

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

Zydus Cadila has received the final approval from the USFDA to market Betamethasone Dipropionate Cream USP (US RLD – DIPROLENE® AF), 0.05%. It will be manufactured at the group’s Topical manufacturing facility at Ahmedabad. This medication is a strong corticosteroid...

Read More

Lupin Pharma developing new products to treat cancer, other diseases

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

Drug maker Lupin is in the process of developing a pipeline of products under its new drug discovery programme to treat various diseases like cancer and metabolic disorders, a top company official said. The company, which last month inked a...

Read More

Eli Lilly to acquire Loxo Oncology for $8 billion

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

Eli Lilly and Company (NYSE: LLY) and Loxo Oncology, Inc. have announced a definitive agreement for Lilly to acquire Loxo Oncology for $235.00 per share in cash, or approximately $8.0 billion. Loxo Oncology is a biopharmaceutical company focused on the...

Read More

IIC program under the Innovation Cell at AICTE launched

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

The Hon’ble Union HRD Minister, launched the IIC program under the Innovation Cell at AICTE, with a purpose to systematically foster a culture of innovation in all Higher Education Institutions across the nation. Talking about Inventive Step, Ms. Shwetasree Majumder,...

Read More

World class Health services at an affordable price

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

Prime Minister Narendra Modi unveiled today the state of art, super-speciality public hospital - Sardar Vallabhbhai Patel Institute of Medical Sciences and Research in Ahmedabad today. Built by Ahmedabad Municipal Corporation, the 78 meter high, 1500 bed hospital is equipped...

Read More

Aurobindo Pharma to acquire portfolio of 7 oncology injectable products from Spectrum Pharma

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

Aurobindo Pharma Limited, announces the signing of a definitive agreement to acquire a portfolio of seven branded oncology injectable products from Spectrum pharmaceuticals Inc. The acquisition also brings-in an experienced branded commercial infrastructure in the US. Acrotech Biopharma LLC (“Acrotech”),...

Read More

Zydus receives approval from USFDA for Acetazolamide ER Capsules

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

Zydus Cadila has received the final approval from the USFDA to market Acetazolamide ER Capsules (US RLD – Diamox). It will be manufactured at the group’s formulations manufacturing facility at Moraiya, Ahmedabad. Acetazolamide is a potent carbonic anhydrase inhibitor. Acetazolamide...

Read More

USFDA announces new policies to advance development of safe and effective cell and gene therapies

  • accuprec_admin
  • Comments : 0
  • July 8, 2021

Statement from FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research: The FDA is witnessing a surge of cell and gene therapy products entering early development, evidenced by a large...

Read More

Accreditations